Report cover image

Europe Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Product, By End User, Based on Specimen, By Technology, By Application (Research, Clinical, and Drug/Therapy Development), By Country and Growth Forecast, 2024 - 2031

Publisher Knowledge Based Value (KBV) Research
Published Jan 10, 2025
Length 122 Pages
SKU # KBV19494115

Description

Europe Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Product, By End User, Based on Specimen, By Technology, By Application (Research, Clinical, and Drug/Therapy Development), By Country and Growth Forecast, 2024 - 2031


The Europe Circulating Tumor Cell Market would witness market growth of 13.0% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Circulating Tumour Cell Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,842.2 million by 2031. UK market is exhibiting a CAGR of 12.1% during (2024 - 2031). Additionally, The France market would experience a CAGR of 13.9% during (2024 - 2031).

The adoption of CTC-based technologies has grown significantly over the past few years, driven by advances in liquid biopsy techniques, an increasing understanding of cancer biology, and a rising demand for less invasive diagnostic methods. Significant breakthroughs in CTC isolation and detection technologies, such as microfluidics, immunomagnetic capture, and imaging techniques, have enabled the accurate and efficient collection of CTCs from blood samples.

Moreover, innovations in molecular analysis, such as next-generation sequencing (NGS) and single-cell RNA sequencing, have further enhanced the ability to profile CTCs and gain insights into their genetic makeup.

The rising incidence of prostate and bladder cancer in Europe is driving a growing demand for advanced diagnostic and monitoring solutions, such as circulating tumor cell technologies. With prostate cancer being the most common cancer among men and bladder cancer ranking fifth in terms of prevalence, there is an urgent need for effective early detection and non-invasive diagnostic methods.

Based on Product, the market is segmented into Kits & Reagents, Devices, and Blood Collection Tubes. Based on End User, the market is segmented into Research and Academic Institutes, Hospital & Clinics, and Diagnostic Centers. Based on Specimen, the market is segmented into Blood, Bone Marrow, and Other Specimen. Based on Technology, the market is segmented into CTC Detection & Enrichment Methods, CTC Analysis, and CTC Direct Detection. Based on Application, the market is segmented into Research, Clinical, and Drug/Therapy Development. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • Qiagen N.V
  • Greiner Bio-One International GmbH
  • Sysmex Corporation
  • Miltenyi Biotech B.V & Co kg
  • Bio-Techne Corporation
  • Ikonisys, Inc.
  • Menarini Silicon Biosystems SpA
  • LungLife AI Inc.
  • Aviva Systems Biology Corporation
  • ScreenCell
Europe Circulating Tumor Cell Market Report Segmentation

By Product
  • Kits & Reagents
  • Devices
  • Blood Collection Tubes
By End User
  • Research and Academic Institutes
  • Hospital & Clinics
  • Diagnostic Centers
By Specimen
  • Blood
  • Bone Marrow
  • Other Specimen
By Technology
  • CTC Detection & Enrichment Methods
  • CTC Analysis
  • CTC Direct Detection
By Application
  • Research, Clinical
  • Drug/Therapy Development
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

122 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Circulating Tumor Cell Market, by Product
1.4.2 Europe Circulating Tumor Cell Market, by End User
1.4.3 Europe Circulating Tumor Cell Market, by Specimen
1.4.4 Europe Circulating Tumor Cell Market, by Technology
1.4.5 Europe Circulating Tumor Cell Market, by Application
1.4.6 Europe Circulating Tumor Cell Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Circulating Tumor Cell Market by Product
4.1 Europe Kits & Reagents Market by Country
4.2 Europe Devices Market by Country
4.3 Europe Blood Collection Tubes Market by Country
Chapter 5. Europe Circulating Tumor Cell Market by End User
5.1 Europe Research and Academic Institutes Market by Country
5.2 Europe Hospital & Clinics Market by Country
5.3 Europe Diagnostic Centers Market by Country
Chapter 6. Europe Circulating Tumor Cell Market by Specimen
6.1 Europe Blood Market by Country
6.2 Europe Bone Marrow Market by Country
6.3 Europe Other Specimen Market by Country
Chapter 7. Europe Circulating Tumor Cell Market by Technology
7.1 Europe CTC Detection & Enrichment Methods Market by Country
7.2 Europe CTC Analysis Market by Country
7.3 Europe CTC Direct Detection Market by Country
Chapter 8. Europe Circulating Tumor Cell Market by Application
8.1 Europe Research, Clinical Market by Country
8.2 Europe Drug/Therapy Development Market by Country
Chapter 9. Europe Circulating Tumor Cell Market by Country
9.1 Germany Circulating Tumor Cell Market
9.1.1 Germany Circulating Tumor Cell Market by Product
9.1.2 Germany Circulating Tumor Cell Market by End User
9.1.3 Germany Circulating Tumor Cell Market by Specimen
9.1.4 Germany Circulating Tumor Cell Market by Technology
9.1.5 Germany Circulating Tumor Cell Market by Application
9.2 UK Circulating Tumor Cell Market
9.2.1 UK Circulating Tumor Cell Market by Product
9.2.2 UK Circulating Tumor Cell Market by End User
9.2.3 UK Circulating Tumor Cell Market by Specimen
9.2.4 UK Circulating Tumor Cell Market by Technology
9.2.5 UK Circulating Tumor Cell Market by Application
9.3 France Circulating Tumor Cell Market
9.3.1 France Circulating Tumor Cell Market by Product
9.3.2 France Circulating Tumor Cell Market by End User
9.3.3 France Circulating Tumor Cell Market by Specimen
9.3.4 France Circulating Tumor Cell Market by Technology
9.3.5 France Circulating Tumor Cell Market by Application
9.4 Russia Circulating Tumor Cell Market
9.4.1 Russia Circulating Tumor Cell Market by Product
9.4.2 Russia Circulating Tumor Cell Market by End User
9.4.3 Russia Circulating Tumor Cell Market by Specimen
9.4.4 Russia Circulating Tumor Cell Market by Technology
9.4.5 Russia Circulating Tumor Cell Market by Application
9.5 Spain Circulating Tumor Cell Market
9.5.1 Spain Circulating Tumor Cell Market by Product
9.5.2 Spain Circulating Tumor Cell Market by End User
9.5.3 Spain Circulating Tumor Cell Market by Specimen
9.5.4 Spain Circulating Tumor Cell Market by Technology
9.5.5 Spain Circulating Tumor Cell Market by Application
9.6 Italy Circulating Tumor Cell Market
9.6.1 Italy Circulating Tumor Cell Market by Product
9.6.2 Italy Circulating Tumor Cell Market by End User
9.6.3 Italy Circulating Tumor Cell Market by Specimen
9.6.4 Italy Circulating Tumor Cell Market by Technology
9.6.5 Italy Circulating Tumor Cell Market by Application
9.7 Rest of Europe Circulating Tumor Cell Market
9.7.1 Rest of Europe Circulating Tumor Cell Market by Product
9.7.2 Rest of Europe Circulating Tumor Cell Market by End User
9.7.3 Rest of Europe Circulating Tumor Cell Market by Specimen
9.7.4 Rest of Europe Circulating Tumor Cell Market by Technology
9.7.5 Rest of Europe Circulating Tumor Cell Market by Application
Chapter 10. Company Profiles
10.1 Qiagen N.V.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.6 SWOT Analysis
10.2 Greiner Bio-One International GmbH
10.2.1 Company Overview
10.2.2 SWOT Analysis
10.3 Sysmex Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Research & Development Expenses
10.3.4 SWOT Analysis
10.4 Miltenyi Biotech B.V. & Co. KG
10.4.1 Company Overview
10.4.2 SWOT Analysis
10.5 Bio-Techne Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Ikonisys, Inc.
10.6.1 Company Overview
10.7 Menarini Silicon Biosystems SpA
10.7.1 Company Overview
10.8 LungLife AI Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.9 Aviva Systems Biology Corporation
10.9.1 Company Overview
10.10. ScreenCell
10.10.1 Company Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us